Rank | Gene Set | Z-score |
---|---|---|
1 | * actin-mediated cell contraction (GO:0070252) | 9.77449950 |
2 | skeletal muscle fiber development (GO:0048741) | 7.95463664 |
3 | * actin filament-based movement (GO:0030048) | 7.27159819 |
4 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.25877198 |
5 | glycogen catabolic process (GO:0005980) | 7.01082096 |
6 | plasma membrane repair (GO:0001778) | 6.99721257 |
7 | sarcomere organization (GO:0045214) | 6.86446540 |
8 | myotube cell development (GO:0014904) | 6.78467176 |
9 | creatine metabolic process (GO:0006600) | 6.71991908 |
10 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.69644451 |
11 | striated muscle contraction (GO:0006941) | 6.66965961 |
12 | glucan catabolic process (GO:0009251) | 6.56507401 |
13 | skeletal muscle tissue regeneration (GO:0043403) | 6.52781393 |
14 | striated muscle atrophy (GO:0014891) | 6.22101615 |
15 | carnitine shuttle (GO:0006853) | 6.21302020 |
16 | cellular polysaccharide catabolic process (GO:0044247) | 6.11251287 |
17 | myofibril assembly (GO:0030239) | 6.05086415 |
18 | polysaccharide catabolic process (GO:0000272) | 5.83947949 |
19 | purine nucleotide salvage (GO:0032261) | 5.81592995 |
20 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.79879110 |
21 | response to muscle activity (GO:0014850) | 5.77308579 |
22 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.76886359 |
23 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.72787367 |
24 | regulation of cell communication by electrical coupling (GO:0010649) | 5.68748558 |
25 | response to inactivity (GO:0014854) | 5.63391613 |
26 | muscle contraction (GO:0006936) | 5.53875204 |
27 | cytidine deamination (GO:0009972) | 5.48040116 |
28 | cytidine metabolic process (GO:0046087) | 5.48040116 |
29 | cytidine catabolic process (GO:0006216) | 5.48040116 |
30 | muscle atrophy (GO:0014889) | 5.38028935 |
31 | striated muscle adaptation (GO:0014888) | 5.36402143 |
32 | fatty acid transmembrane transport (GO:1902001) | 5.25138672 |
33 | glucan biosynthetic process (GO:0009250) | 5.19932928 |
34 | glycogen biosynthetic process (GO:0005978) | 5.19932928 |
35 | IMP metabolic process (GO:0046040) | 5.13200165 |
36 | NADH metabolic process (GO:0006734) | 5.07451307 |
37 | muscle system process (GO:0003012) | 4.94569592 |
38 | muscle fiber development (GO:0048747) | 4.88924133 |
39 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.87688409 |
40 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.80930928 |
41 | actomyosin structure organization (GO:0031032) | 4.76620724 |
42 | glycogen metabolic process (GO:0005977) | 4.63150179 |
43 | fructose metabolic process (GO:0006000) | 4.62674982 |
44 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.61756741 |
45 | carnitine transmembrane transport (GO:1902603) | 4.60289853 |
46 | cellular glucan metabolic process (GO:0006073) | 4.53867360 |
47 | glucan metabolic process (GO:0044042) | 4.53867360 |
48 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.50055728 |
49 | cardiac muscle hypertrophy (GO:0003300) | 4.45116546 |
50 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.43647486 |
51 | negative regulation of muscle hypertrophy (GO:0014741) | 4.36509883 |
52 | muscle adaptation (GO:0043500) | 4.34892274 |
53 | muscle cell fate commitment (GO:0042693) | 4.25876044 |
54 | striated muscle hypertrophy (GO:0014897) | 4.24797892 |
55 | carnitine transport (GO:0015879) | 4.20309016 |
56 | amino-acid betaine transport (GO:0015838) | 4.20309016 |
57 | gluconeogenesis (GO:0006094) | 4.15975076 |
58 | 2-oxoglutarate metabolic process (GO:0006103) | 4.15876945 |
59 | muscle organ morphogenesis (GO:0048644) | 4.14134764 |
60 | cardiac muscle contraction (GO:0060048) | 4.07350961 |
61 | negative regulation of skeletal muscle tissue development (GO:0048642) | 4.05585088 |
62 | response to activity (GO:0014823) | 4.04899626 |
63 | regulation of coenzyme metabolic process (GO:0051196) | 4.00871853 |
64 | regulation of cofactor metabolic process (GO:0051193) | 4.00871853 |
65 | IMP biosynthetic process (GO:0006188) | 3.98779672 |
66 | neuronal action potential propagation (GO:0019227) | 3.93328395 |
67 | cellular carbohydrate catabolic process (GO:0044275) | 3.92746859 |
68 | cellular response to dexamethasone stimulus (GO:0071549) | 3.90218827 |
69 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.86503526 |
70 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.84713065 |
71 | muscle hypertrophy (GO:0014896) | 3.80785526 |
72 | muscle tissue morphogenesis (GO:0060415) | 3.79410437 |
73 | regulation of relaxation of muscle (GO:1901077) | 3.73391153 |
74 | hexose biosynthetic process (GO:0019319) | 3.73382237 |
75 | striated muscle cell development (GO:0055002) | 3.73121792 |
76 | muscle organ development (GO:0007517) | 3.73042413 |
77 | muscle cell cellular homeostasis (GO:0046716) | 3.70683338 |
78 | muscle structure development (GO:0061061) | 3.67943719 |
79 | tricarboxylic acid cycle (GO:0006099) | 3.67832570 |
80 | response to dexamethasone (GO:0071548) | 3.63403887 |
81 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.60751726 |
82 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.60751726 |
83 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.58379687 |
84 | adult heart development (GO:0007512) | 3.58203632 |
85 | neuromuscular synaptic transmission (GO:0007274) | 3.56691716 |
86 | negative regulation of muscle contraction (GO:0045932) | 3.55587073 |
87 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.52612975 |
88 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.50183474 |
89 | myotube differentiation (GO:0014902) | 3.45127204 |
90 | regulation of actin filament-based movement (GO:1903115) | 3.44883685 |
91 | regulation of striated muscle contraction (GO:0006942) | 3.42560857 |
92 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.40677222 |
93 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.40677222 |
94 | ubiquinone biosynthetic process (GO:0006744) | 3.38626205 |
95 | striated muscle tissue development (GO:0014706) | 3.38461364 |
96 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.38050626 |
97 | skeletal muscle tissue development (GO:0007519) | 3.35739898 |
98 | cardiac muscle adaptation (GO:0014887) | 3.35110027 |
99 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.35110027 |
100 | muscle hypertrophy in response to stress (GO:0003299) | 3.35110027 |
101 | heart process (GO:0003015) | 3.34479528 |
102 | heart contraction (GO:0060047) | 3.34479528 |
103 | cardiac myofibril assembly (GO:0055003) | 3.33129429 |
104 | regulation of sulfur metabolic process (GO:0042762) | 3.31821859 |
105 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.29329836 |
106 | relaxation of muscle (GO:0090075) | 3.29298302 |
107 | regulation of myoblast differentiation (GO:0045661) | 3.25389445 |
108 | cellular polysaccharide metabolic process (GO:0044264) | 3.24162219 |
109 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.23131374 |
110 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.20414388 |
111 | positive regulation of cation channel activity (GO:2001259) | 3.20048744 |
112 | positive regulation of myotube differentiation (GO:0010831) | 3.19525930 |
113 | muscle cell development (GO:0055001) | 3.17984115 |
114 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.13762950 |
115 | myoblast fusion (GO:0007520) | 3.11810616 |
116 | intracellular lipid transport (GO:0032365) | 3.07000212 |
117 | cellular polysaccharide biosynthetic process (GO:0033692) | 3.06775162 |
118 | cardiac muscle cell development (GO:0055013) | 3.06459891 |
119 | neuromuscular junction development (GO:0007528) | 3.02904735 |
120 | polysaccharide biosynthetic process (GO:0000271) | 3.02155779 |
121 | regulation of skeletal muscle contraction (GO:0014819) | 12.7212155 |
122 | * muscle filament sliding (GO:0030049) | 11.9882218 |
123 | * actin-myosin filament sliding (GO:0033275) | 11.9882218 |
124 | skeletal muscle contraction (GO:0003009) | 10.8647505 |
125 | skeletal muscle adaptation (GO:0043501) | 10.2983272 |
126 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.2133975 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.69463045 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.04495870 |
3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.50674604 |
4 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.39695380 |
5 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.15328400 |
6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.15267047 |
7 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.84668793 |
8 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.84560326 |
9 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.59770136 |
10 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.57296273 |
11 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.57296273 |
12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.30639606 |
13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.30295885 |
14 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.24616386 |
15 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.87428228 |
16 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.86842845 |
17 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.83095305 |
18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.82696035 |
19 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.81322654 |
20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.80678986 |
21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.77373118 |
22 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.72539021 |
23 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.72377559 |
24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.64864334 |
25 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.62818725 |
26 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.59730069 |
27 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.58328622 |
28 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.54242547 |
29 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.52633548 |
30 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.50572386 |
31 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.49339326 |
32 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.48228233 |
33 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.47533880 |
34 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.46518927 |
35 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.44851768 |
36 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.43622739 |
37 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.40050756 |
38 | SA1_27219007_Chip-Seq_Bcells_Human | 1.37749976 |
39 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.37183836 |
40 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.37009775 |
41 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.36728038 |
42 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.33678237 |
43 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33347426 |
44 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.33203288 |
45 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.32356504 |
46 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.29989498 |
47 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.28323255 |
48 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.24732089 |
49 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.21953105 |
50 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.21942273 |
51 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.21537754 |
52 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.19227709 |
53 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.18576110 |
54 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.17252174 |
55 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.17237892 |
56 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.15794736 |
57 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15000356 |
58 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14439427 |
59 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.13554359 |
60 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12945895 |
61 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.11989761 |
62 | P68_20966046_ChIP-Seq_HELA_Human | 1.11603735 |
63 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.11499952 |
64 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11217818 |
65 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08633249 |
66 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.08483928 |
67 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.06799854 |
68 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.06642602 |
69 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.05450183 |
70 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.05299133 |
71 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05182354 |
72 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.04981893 |
73 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.04845884 |
74 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.03176262 |
75 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.02896361 |
76 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.02818005 |
77 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.01743096 |
78 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.01218671 |
79 | ATF3_27146783_Chip-Seq_COLON_Human | 1.00443516 |
80 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.98595290 |
81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98514206 |
82 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98167702 |
83 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.98161912 |
84 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.97267110 |
85 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97167001 |
86 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96599057 |
87 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.96456109 |
88 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.96456109 |
89 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.96055765 |
90 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95807034 |
91 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.95792550 |
92 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95750512 |
93 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.95737996 |
94 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.95523287 |
95 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.95109816 |
96 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.95056839 |
97 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 0.95052109 |
98 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95006894 |
99 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.94640115 |
100 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.93967406 |
101 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.93904933 |
102 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.93420410 |
103 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.92628853 |
104 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.92099310 |
105 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.92009617 |
106 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 0.91844191 |
107 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.91306846 |
108 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.90672790 |
109 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.90659275 |
110 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.90092425 |
111 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.89934610 |
112 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.89520241 |
113 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87030381 |
114 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.86635200 |
115 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.86506820 |
116 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.85855007 |
117 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.85707056 |
118 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.85369651 |
119 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.84345634 |
120 | CJUN_26792858_Chip-Seq_BT549_Human | 0.84050347 |
121 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.83679001 |
122 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.83592323 |
123 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.82217541 |
124 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82113136 |
125 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.82097412 |
126 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.82077254 |
127 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.81260089 |
128 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.77701780 |
129 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.76220266 |
130 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.74140332 |
131 | * DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.71426787 |
132 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.70377982 |
133 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.69689143 |
134 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.69200478 |
135 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.69061786 |
136 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.69061786 |
137 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.69013583 |
138 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.68600738 |
139 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.68425169 |
140 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.68043162 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004145_abnormal_muscle_electrophysio | 7.85406928 |
2 | MP0003646_muscle_fatigue | 6.50171253 |
3 | MP0000749_muscle_degeneration | 6.29349946 |
4 | MP0000751_myopathy | 5.66604988 |
5 | MP0000747_muscle_weakness | 4.45164893 |
6 | MP0002106_abnormal_muscle_physiology | 4.22515820 |
7 | MP0004036_abnormal_muscle_relaxation | 4.15522995 |
8 | MP0000759_abnormal_skeletal_muscle | 3.80469529 |
9 | MP0002837_dystrophic_cardiac_calcinosis | 3.78937568 |
10 | MP0002269_muscular_atrophy | 3.55770171 |
11 | MP0005369_muscle_phenotype | 3.52002073 |
12 | MP0004130_abnormal_muscle_cell | 3.42189781 |
13 | MP0004087_abnormal_muscle_fiber | 3.41548730 |
14 | MP0000750_abnormal_muscle_regeneration | 3.25851692 |
15 | MP0005620_abnormal_muscle_contractility | 3.17759270 |
16 | MP0004233_abnormal_muscle_weight | 2.56715603 |
17 | MP0000733_abnormal_muscle_development | 2.26958580 |
18 | MP0002332_abnormal_exercise_endurance | 2.24084959 |
19 | MP0002108_abnormal_muscle_morphology | 2.03812443 |
20 | MP0005330_cardiomyopathy | 1.93455858 |
21 | MP0006036_abnormal_mitochondrial_physio | 1.89335707 |
22 | MP0004185_abnormal_adipocyte_glucose | 1.87658374 |
23 | MP0004084_abnormal_cardiac_muscle | 1.82980960 |
24 | MP0005666_abnormal_adipose_tissue | 1.52384014 |
25 | MP0004215_abnormal_myocardial_fiber | 1.41457628 |
26 | MP0002971_abnormal_brown_adipose | 1.37857950 |
27 | MP0002972_abnormal_cardiac_muscle | 1.32692053 |
28 | MP0005275_abnormal_skin_tensile | 1.26556427 |
29 | MP0004270_analgesia | 1.23383928 |
30 | MP0010630_abnormal_cardiac_muscle | 1.23219272 |
31 | MP0004484_altered_response_of | 1.22314388 |
32 | MP0003221_abnormal_cardiomyocyte_apopto | 1.20622944 |
33 | MP0003806_abnormal_nucleotide_metabolis | 1.16761553 |
34 | MP0005375_adipose_tissue_phenotype | 1.12596703 |
35 | MP0003705_abnormal_hypodermis_morpholog | 1.11693823 |
36 | MP0005266_abnormal_metabolism | 1.04081936 |
37 | MP0002822_catalepsy | 1.02199947 |
38 | MP0001661_extended_life_span | 1.01892730 |
39 | MP0000013_abnormal_adipose_tissue | 0.98421489 |
40 | MP0006035_abnormal_mitochondrial_morpho | 0.97707168 |
41 | MP0003950_abnormal_plasma_membrane | 0.96761918 |
42 | MP0001544_abnormal_cardiovascular_syste | 0.94511971 |
43 | MP0005385_cardiovascular_system_phenoty | 0.94511971 |
44 | MP0004134_abnormal_chest_morphology | 0.84349152 |
45 | MP0005670_abnormal_white_adipose | 0.80847896 |
46 | MP0003137_abnormal_impulse_conducting | 0.79004655 |
47 | MP0003656_abnormal_erythrocyte_physiolo | 0.75615702 |
48 | MP0009780_abnormal_chondrocyte_physiolo | 0.75527316 |
49 | MP0002234_abnormal_pharynx_morphology | 0.74287680 |
50 | MP0005334_abnormal_fat_pad | 0.67072457 |
51 | MP0009250_abnormal_appendicular_skeleto | 0.66480238 |
52 | MP0004147_increased_porphyrin_level | 0.66253292 |
53 | MP0008961_abnormal_basal_metabolism | 0.65303202 |
54 | MP0004043_abnormal_pH_regulation | 0.64945793 |
55 | MP0000762_abnormal_tongue_morphology | 0.64245590 |
56 | MP0002078_abnormal_glucose_homeostasis | 0.61858610 |
57 | MP0001299_abnormal_eye_distance/ | 0.61327688 |
58 | MP0000372_irregular_coat_pigmentation | 0.61248491 |
59 | MP0008775_abnormal_heart_ventricle | 0.60429933 |
60 | MP0000003_abnormal_adipose_tissue | 0.59656773 |
61 | MP0003879_abnormal_hair_cell | 0.55857899 |
62 | MP0000343_altered_response_to | 0.54658018 |
63 | MP0000266_abnormal_heart_morphology | 0.54631419 |
64 | MP0002796_impaired_skin_barrier | 0.53642795 |
65 | MP0002127_abnormal_cardiovascular_syste | 0.51608071 |
66 | MP0010030_abnormal_orbit_morphology | 0.49283484 |
67 | MP0001849_ear_inflammation | 0.46753241 |
68 | MP0005452_abnormal_adipose_tissue | 0.46636930 |
69 | MP0000579_abnormal_nail_morphology | 0.46132376 |
70 | MP0001346_abnormal_lacrimal_gland | 0.45696739 |
71 | MP0002089_abnormal_postnatal_growth/wei | 0.45600393 |
72 | MP0006138_congestive_heart_failure | 0.45584068 |
73 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.44811581 |
74 | MP0009672_abnormal_birth_weight | 0.42949832 |
75 | MP0003959_abnormal_lean_body | 0.42837038 |
76 | MP0002896_abnormal_bone_mineralization | 0.42512928 |
77 | MP0003045_fibrosis | 0.42177699 |
78 | MP0005083_abnormal_biliary_tract | 0.41677048 |
79 | MP0005503_abnormal_tendon_morphology | 0.41364141 |
80 | MP0008569_lethality_at_weaning | 0.41013877 |
81 | MP0002638_abnormal_pupillary_reflex | 0.37890786 |
82 | MP0005167_abnormal_blood-brain_barrier | 0.36634379 |
83 | MP0005166_decreased_susceptibility_to | 0.35751764 |
84 | MP0005319_abnormal_enzyme/_coenzyme | 0.34308183 |
85 | MP0009115_abnormal_fat_cell | 0.34207209 |
86 | MP0000383_abnormal_hair_follicle | 0.33867119 |
87 | MP0001243_abnormal_dermal_layer | 0.33219765 |
88 | MP0004510_myositis | 0.32806037 |
89 | MP0003948_abnormal_gas_homeostasis | 0.31464042 |
90 | MP0008438_abnormal_cutaneous_collagen | 0.31273635 |
91 | MP0002734_abnormal_mechanical_nocicepti | 0.30670256 |
92 | MP0004085_abnormal_heartbeat | 0.29985081 |
93 | MP0002114_abnormal_axial_skeleton | 0.29234332 |
94 | MP0004142_abnormal_muscle_tone | 0.29041974 |
95 | MP0000230_abnormal_systemic_arterial | 0.29035452 |
96 | MP0005332_abnormal_amino_acid | 0.28856685 |
97 | MP0003828_pulmonary_edema | 0.28796465 |
98 | MP0005423_abnormal_somatic_nervous | 0.26895118 |
99 | MP0002118_abnormal_lipid_homeostasis | 0.26290565 |
100 | MP0005451_abnormal_body_composition | 0.24628230 |
101 | MP0005535_abnormal_body_temperature | 0.24535549 |
102 | MP0003567_abnormal_fetal_cardiomyocyte | 0.23714558 |
103 | MP0005376_homeostasis/metabolism_phenot | 0.22889910 |
104 | MP0002066_abnormal_motor_capabilities/c | 0.22172561 |
105 | MP0002128_abnormal_blood_circulation | 0.21672335 |
106 | MP0002060_abnormal_skin_morphology | 0.21286906 |
107 | MP0001853_heart_inflammation | 0.20258788 |
108 | MP0008770_decreased_survivor_rate | 0.19811475 |
109 | MP0005165_increased_susceptibility_to | 0.19441357 |
110 | MP0004858_abnormal_nervous_system | 0.18161051 |
111 | MP0002970_abnormal_white_adipose | 0.18023042 |
112 | MP0005501_abnormal_skin_physiology | 0.17999260 |
113 | MP0000427_abnormal_hair_cycle | 0.17319094 |
114 | MP0001943_abnormal_respiration | 0.17239058 |
115 | MP0010678_abnormal_skin_adnexa | 0.17078095 |
116 | MP0000678_abnormal_parathyroid_gland | 0.16279699 |
117 | MP0005187_abnormal_penis_morphology | 0.15842514 |
118 | MP0002067_abnormal_sensory_capabilities | 0.14602320 |
119 | MP0002249_abnormal_larynx_morphology | 0.14452174 |
120 | MP0002876_abnormal_thyroid_physiology | 0.14284479 |
121 | MP0004197_abnormal_fetal_growth/weight/ | 0.13748291 |
122 | MP0008874_decreased_physiological_sensi | 0.12287476 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Muscle fiber inclusion bodies (HP:0100299) | 9.55899295 |
2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.21926767 |
3 | Exercise-induced myalgia (HP:0003738) | 9.04343971 |
4 | Nemaline bodies (HP:0003798) | 8.58858342 |
5 | Exercise-induced muscle cramps (HP:0003710) | 8.28451423 |
6 | Distal arthrogryposis (HP:0005684) | 7.26780140 |
7 | Type 1 muscle fiber predominance (HP:0003803) | 7.12260104 |
8 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.85488309 |
9 | Myopathic facies (HP:0002058) | 6.70560459 |
10 | Round ear (HP:0100830) | 6.34508799 |
11 | Ulnar deviation of the wrist (HP:0003049) | 6.22423512 |
12 | Calf muscle hypertrophy (HP:0008981) | 6.07602803 |
13 | Difficulty running (HP:0009046) | 5.56366142 |
14 | Myoglobinuria (HP:0002913) | 5.50131754 |
15 | Muscle fiber splitting (HP:0003555) | 5.43715074 |
16 | Calcaneovalgus deformity (HP:0001848) | 5.40208296 |
17 | Deformed tarsal bones (HP:0008119) | 5.06951134 |
18 | Absent phalangeal crease (HP:0006109) | 4.98880878 |
19 | Hyporeflexia of lower limbs (HP:0002600) | 4.88665967 |
20 | Muscle stiffness (HP:0003552) | 4.82427343 |
21 | Rhabdomyolysis (HP:0003201) | 4.60596457 |
22 | Increased connective tissue (HP:0009025) | 4.60439686 |
23 | EMG: myopathic abnormalities (HP:0003458) | 4.54088681 |
24 | Myotonia (HP:0002486) | 4.23601563 |
25 | Abnormal finger flexion creases (HP:0006143) | 4.16877635 |
26 | Abnormality of the calf musculature (HP:0001430) | 4.07778391 |
27 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.87305676 |
28 | Subaortic stenosis (HP:0001682) | 3.73104324 |
29 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.73104324 |
30 | Increased variability in muscle fiber diameter (HP:0003557) | 3.48592038 |
31 | Malignant hyperthermia (HP:0002047) | 3.47461636 |
32 | Rimmed vacuoles (HP:0003805) | 3.46042217 |
33 | Neck muscle weakness (HP:0000467) | 3.45627504 |
34 | Difficulty climbing stairs (HP:0003551) | 3.41230036 |
35 | Abnormality of the calcaneus (HP:0008364) | 3.25261829 |
36 | Frequent falls (HP:0002359) | 3.20583738 |
37 | Pelvic girdle muscle weakness (HP:0003749) | 3.19326002 |
38 | Shoulder girdle muscle weakness (HP:0003547) | 3.18938895 |
39 | Areflexia of lower limbs (HP:0002522) | 3.16006175 |
40 | Hyperkalemia (HP:0002153) | 3.12974994 |
41 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.08656604 |
42 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.08656604 |
43 | Asymmetric septal hypertrophy (HP:0001670) | 2.93137156 |
44 | Sudden death (HP:0001699) | 2.80910241 |
45 | Bundle branch block (HP:0011710) | 2.74136796 |
46 | Slender build (HP:0001533) | 2.66032577 |
47 | Paralysis (HP:0003470) | 2.62068028 |
48 | Abnormality of the neuromuscular junction (HP:0003398) | 2.53591256 |
49 | Fatigable weakness (HP:0003473) | 2.53591256 |
50 | EMG: neuropathic changes (HP:0003445) | 2.47480249 |
51 | Distal lower limb muscle weakness (HP:0009053) | 2.45747363 |
52 | Muscular dystrophy (HP:0003560) | 2.40094920 |
53 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.27788682 |
54 | Limb-girdle muscle weakness (HP:0003325) | 2.25800415 |
55 | Hypoplastic ischia (HP:0003175) | 2.22115520 |
56 | Generalized muscle weakness (HP:0003324) | 2.18716476 |
57 | Spinal rigidity (HP:0003306) | 2.14928889 |
58 | Nonprogressive disorder (HP:0003680) | 2.13528632 |
59 | Bulbar palsy (HP:0001283) | 2.13406075 |
60 | Proximal amyotrophy (HP:0007126) | 2.13288898 |
61 | Metatarsus adductus (HP:0001840) | 2.06661824 |
62 | Ulnar deviation of finger (HP:0009465) | 2.06476670 |
63 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.04749595 |
64 | Scapular winging (HP:0003691) | 2.02924605 |
65 | Facial diplegia (HP:0001349) | 2.01341026 |
66 | Limb-girdle muscle atrophy (HP:0003797) | 2.00880309 |
67 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.00067881 |
68 | Popliteal pterygium (HP:0009756) | 1.98094522 |
69 | Ventricular tachycardia (HP:0004756) | 1.96360377 |
70 | Abnormality of the ischium (HP:0003174) | 1.94059651 |
71 | Gowers sign (HP:0003391) | 1.93520540 |
72 | Abnormality of the foot musculature (HP:0001436) | 1.90409099 |
73 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.90253411 |
74 | Distal lower limb amyotrophy (HP:0008944) | 1.90083248 |
75 | Achilles tendon contracture (HP:0001771) | 1.84479826 |
76 | Weak cry (HP:0001612) | 1.81270535 |
77 | Waddling gait (HP:0002515) | 1.77698430 |
78 | Heart block (HP:0012722) | 1.77658632 |
79 | Foot dorsiflexor weakness (HP:0009027) | 1.76884976 |
80 | Progressive muscle weakness (HP:0003323) | 1.76151334 |
81 | Long clavicles (HP:0000890) | 1.75812660 |
82 | Type 2 muscle fiber atrophy (HP:0003554) | 1.75534656 |
83 | Tarsal synostosis (HP:0008368) | 1.75254525 |
84 | Hyperuricemia (HP:0002149) | 1.70986724 |
85 | Increased purine levels (HP:0004368) | 1.70986724 |
86 | Ragged-red muscle fibers (HP:0003200) | 1.69753290 |
87 | Abnormality of the Achilles tendon (HP:0005109) | 1.67445529 |
88 | Abnormal atrioventricular conduction (HP:0005150) | 1.66479727 |
89 | Stridor (HP:0010307) | 1.65267311 |
90 | Gout (HP:0001997) | 1.63834554 |
91 | Muscle fiber atrophy (HP:0100295) | 1.63430543 |
92 | Cholelithiasis (HP:0001081) | 1.61379769 |
93 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.60877076 |
94 | Fetal akinesia sequence (HP:0001989) | 1.60426955 |
95 | Abnormality of potassium homeostasis (HP:0011042) | 1.60234945 |
96 | Lipoatrophy (HP:0100578) | 1.59813394 |
97 | Synostosis involving bones of the feet (HP:0009140) | 1.57238962 |
98 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.57238962 |
99 | Short palpebral fissure (HP:0012745) | 1.57008354 |
100 | Increased density of long bones (HP:0006392) | 1.56026017 |
101 | Increased intramyocellular lipid droplets (HP:0012240) | 1.55672506 |
102 | Oligomenorrhea (HP:0000876) | 1.54897050 |
103 | Dilated cardiomyopathy (HP:0001644) | 1.52934411 |
104 | Ventricular arrhythmia (HP:0004308) | 1.46388079 |
105 | Adducted thumb (HP:0001181) | 1.45813691 |
106 | Abnormality of placental membranes (HP:0011409) | 1.45732339 |
107 | Amniotic constriction ring (HP:0009775) | 1.45732339 |
108 | Exercise intolerance (HP:0003546) | 1.44209527 |
109 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.44063614 |
110 | Hip contracture (HP:0003273) | 1.43960009 |
111 | Increased muscle lipid content (HP:0009058) | 1.43562703 |
112 | Congenital hip dislocation (HP:0001374) | 1.43459594 |
113 | Abnormal gallbladder morphology (HP:0012437) | 1.41663759 |
114 | Toxemia of pregnancy (HP:0100603) | 1.39865723 |
115 | Lower limb amyotrophy (HP:0007210) | 1.38807025 |
116 | Limited hip movement (HP:0008800) | 1.37828647 |
117 | Easy fatigability (HP:0003388) | 1.32289251 |
118 | Steppage gait (HP:0003376) | 1.28199405 |
Rank | Gene Set | Z-score |
---|---|---|
1 | OBSCN | 7.90727629 |
2 | TTN | 6.42368140 |
3 | PHKG1 | 6.06803284 |
4 | PHKG2 | 6.06803284 |
5 | NME1 | 4.43284876 |
6 | PIK3CG | 3.48382103 |
7 | MAP2K3 | 2.90107625 |
8 | NEK1 | 2.42961596 |
9 | MAP3K7 | 2.12350025 |
10 | PDK3 | 2.05143418 |
11 | PDK4 | 2.05143418 |
12 | PINK1 | 2.04672277 |
13 | TRIB3 | 1.96063440 |
14 | PIK3CA | 1.75900369 |
15 | DMPK | 1.73487581 |
16 | BCKDK | 1.66071108 |
17 | MAPK12 | 1.62515034 |
18 | MAP2K4 | 1.58814753 |
19 | MAP2K6 | 1.41516165 |
20 | PDK2 | 1.35205233 |
21 | MUSK | 1.08258738 |
22 | PRKAA2 | 0.96156178 |
23 | MAP3K3 | 0.94603421 |
24 | MARK1 | 0.91912254 |
25 | MAPKAPK3 | 0.90542760 |
26 | PRKAA1 | 0.89976270 |
27 | NEK9 | 0.88670077 |
28 | CCNB1 | 0.87699535 |
29 | MAP3K13 | 0.72625189 |
30 | STK24 | 0.71367200 |
31 | TAOK2 | 0.71203202 |
32 | TRPM7 | 0.69108075 |
33 | ERBB3 | 0.68082996 |
34 | PKN2 | 0.63643586 |
35 | ZAK | 0.62585773 |
36 | SIK1 | 0.60958583 |
37 | MAPK11 | 0.60672044 |
38 | EPHB1 | 0.57338096 |
39 | TAOK1 | 0.56691438 |
40 | CAMK4 | 0.56352733 |
41 | CAMK2G | 0.55839472 |
42 | RIPK1 | 0.55293345 |
43 | MAP3K11 | 0.55006695 |
44 | AKT2 | 0.52710128 |
45 | ILK | 0.43426288 |
46 | PTK6 | 0.41249868 |
47 | CAMK1 | 0.38031600 |
48 | CAMK2A | 0.36932612 |
49 | EEF2K | 0.36720041 |
50 | CAMK2B | 0.36108439 |
51 | TBK1 | 0.32722145 |
52 | SGK1 | 0.32350026 |
53 | PKN1 | 0.32318256 |
54 | MAP3K6 | 0.31832260 |
55 | PRKACB | 0.30889784 |
56 | MAP3K5 | 0.29371747 |
57 | SGK2 | 0.28751959 |
58 | MAP3K1 | 0.27592833 |
59 | RPS6KB1 | 0.27436467 |
60 | LIMK1 | 0.27283207 |
61 | CAMK1G | 0.26013011 |
62 | KSR2 | 0.25773924 |
63 | PRKG1 | 0.25400436 |
64 | MAP3K10 | 0.25391824 |
65 | PRPF4B | 0.25192479 |
66 | RPS6KA3 | 0.25145643 |
67 | ARAF | 0.24513417 |
68 | MAPK13 | 0.23974584 |
69 | CDK19 | 0.23761041 |
70 | PRKD1 | 0.23433956 |
71 | TIE1 | 0.22938204 |
72 | MAPK7 | 0.20481801 |
73 | ERN1 | 0.20407028 |
74 | PRKACA | 0.20181011 |
75 | ROCK1 | 0.19385835 |
76 | MAPK4 | 0.19344653 |
77 | MARK2 | 0.18333234 |
78 | PDPK1 | 0.16256513 |
79 | TYK2 | 0.15894425 |
80 | PNCK | 0.15306330 |
81 | MAP2K1 | 0.15172051 |
82 | LATS1 | 0.14571789 |
83 | TGFBR2 | 0.14180987 |
84 | LATS2 | 0.13625467 |
85 | DAPK2 | 0.13467142 |
86 | PDK1 | 0.12216476 |
87 | MARK3 | 0.11884192 |
88 | RPS6KL1 | 0.11698388 |
89 | RPS6KC1 | 0.11698388 |
90 | PAK6 | 0.11095425 |
91 | INSRR | 0.10976991 |
92 | RPS6KA1 | 0.10791655 |
93 | FER | 0.10554084 |
94 | SGK494 | 0.10440025 |
95 | SGK223 | 0.10440025 |
96 | RAF1 | 0.09729762 |
97 | LRRK2 | 0.09650906 |
98 | BRAF | 0.09267983 |
99 | CAMK2D | 0.08492819 |
100 | RPS6KA6 | 0.07812463 |
101 | DYRK1B | 0.07691923 |
102 | ZAP70 | 0.07617900 |
103 | PRKACG | 0.07249061 |
104 | MTOR | 0.06999517 |
105 | NLK | 0.06346614 |
106 | DDR2 | 0.06210229 |
107 | ICK | 0.06040025 |
108 | BMX | 0.05557836 |
109 | MAP3K9 | 0.05465256 |
110 | SGK3 | 0.05450793 |
111 | GSK3A | 0.04085095 |
112 | FGFR1 | 0.04074555 |
113 | MST1R | 0.04072910 |
114 | JAK2 | 0.03825249 |
115 | STK11 | 0.03386284 |
116 | MAPK10 | 0.03356735 |
117 | KSR1 | 0.02972265 |
118 | MOS | 0.02853780 |
119 | GSK3B | 0.02596269 |
120 | MAPK8 | 0.02569234 |
121 | CSNK1D | 0.02320334 |
122 | MAPK3 | 0.02245234 |
123 | ROCK2 | 0.01891371 |
124 | RPS6KB2 | 0.00334356 |
125 | RPS6KA2 | 0.00172816 |
126 | PRKDC | -0.0294077 |
127 | FGFR3 | -0.0283295 |
128 | PDGFRA | -0.0208032 |
129 | MAPK9 | -0.0112498 |
130 | PTK2B | -0.0004687 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.33925395 |
2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.17466216 |
3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.67782207 |
4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.49290247 |
5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.40788754 |
6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.34125715 |
7 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 3.09223380 |
8 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.43874185 |
9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.43616400 |
10 | Circadian rhythm_Homo sapiens_hsa04710 | 2.36386874 |
11 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.34832211 |
12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.26681040 |
13 | Insulin resistance_Homo sapiens_hsa04931 | 2.21694591 |
14 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.18826421 |
15 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.14171598 |
16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.07253948 |
17 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.86709530 |
18 | Galactose metabolism_Homo sapiens_hsa00052 | 1.83187055 |
19 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.76999554 |
20 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.71222918 |
21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.67437731 |
22 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.65153114 |
23 | Parkinsons disease_Homo sapiens_hsa05012 | 1.63633935 |
24 | Alzheimers disease_Homo sapiens_hsa05010 | 1.58207848 |
25 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.57434798 |
26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.56774019 |
27 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.53879038 |
28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.49512803 |
29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.48923667 |
30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.40901679 |
31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.37784675 |
32 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.37411220 |
33 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.33075491 |
34 | Tight junction_Homo sapiens_hsa04530 | 1.32100509 |
35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.32008793 |
36 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.28417790 |
37 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.23971986 |
38 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.10889352 |
39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.08106665 |
40 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.07052160 |
41 | Focal adhesion_Homo sapiens_hsa04510 | 1.04525178 |
42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.01907161 |
43 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.98364276 |
44 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.93868296 |
45 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.91206601 |
46 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.89550009 |
47 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.88004548 |
48 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.82764481 |
49 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.82302984 |
50 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.79530906 |
51 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.76307074 |
52 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.72619812 |
53 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.72485510 |
54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70690170 |
55 | Renin secretion_Homo sapiens_hsa04924 | 0.65722168 |
56 | Huntingtons disease_Homo sapiens_hsa05016 | 0.64727856 |
57 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59981277 |
58 | Platelet activation_Homo sapiens_hsa04611 | 0.55623626 |
59 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.55271274 |
60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.52075111 |
61 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.49674413 |
62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48245170 |
63 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47940028 |
64 | Adherens junction_Homo sapiens_hsa04520 | 0.46900120 |
65 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45194182 |
66 | Amoebiasis_Homo sapiens_hsa05146 | 0.45096262 |
67 | Insulin secretion_Homo sapiens_hsa04911 | 0.41564372 |
68 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.39928304 |
69 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37638514 |
70 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.37011286 |
71 | Salivary secretion_Homo sapiens_hsa04970 | 0.35961415 |
72 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.32593036 |
73 | Lysine degradation_Homo sapiens_hsa00310 | 0.29398251 |
74 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.28037977 |
75 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27297260 |
76 | Glioma_Homo sapiens_hsa05214 | 0.25725683 |
77 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.24981007 |
78 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.24630995 |
79 | Histidine metabolism_Homo sapiens_hsa00340 | 0.24116546 |
80 | Long-term depression_Homo sapiens_hsa04730 | 0.23654169 |
81 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.21727949 |
82 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.21430566 |
83 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.21149661 |
84 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.18420197 |
85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.18313334 |
86 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.17667482 |
87 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16427627 |
88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.15598579 |
89 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.15483413 |
90 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.15381474 |
91 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.15291293 |
92 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.14375393 |
93 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.14055704 |
94 | Peroxisome_Homo sapiens_hsa04146 | 0.14040279 |
95 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.13270512 |
96 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.11911212 |
97 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.10325047 |
98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.09535952 |
99 | Metabolic pathways_Homo sapiens_hsa01100 | 0.08960834 |
100 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.08323634 |
101 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.07914938 |
102 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.07442901 |
103 | Circadian entrainment_Homo sapiens_hsa04713 | 0.07193607 |
104 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.06936588 |
105 | Sulfur relay system_Homo sapiens_hsa04122 | 0.06715816 |
106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.06459843 |
107 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.06277314 |
108 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.05731179 |
109 | Melanogenesis_Homo sapiens_hsa04916 | 0.05559519 |
110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.05067267 |
111 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.04487856 |
112 | Purine metabolism_Homo sapiens_hsa00230 | 0.04343038 |
113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.04257544 |
114 | ABC transporters_Homo sapiens_hsa02010 | 0.04124487 |
115 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.03464388 |
116 | Long-term potentiation_Homo sapiens_hsa04720 | 0.03130639 |